Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

DCPH Stock Alert: Why Is Deciphera Pharmaceuticals Plunging 70%?

Today, investors in Deciphera Pharmaceuticals and DCPH stock have seen tremendous selling pressure take this stock to all-time lows.

ALZN Stock: Why Is Little-Known Alzamend Neuro Gaining Today?

Today, investors in preclinical biotech company Alzamend Neuro and ALZN stock are seeing impressive gains of more than 25% currently.

WKHS Stock Plunges Because Workhorse Is Under a Second Investigation

Today, a new Department of Justice probe into Workhorse has sent shares of WKHS stock tumbling 10% in earlier trading on obvious concerns.

LCID Stock Alert: What Is Going on With Lucid Motors Today?

Here are a couple of key news items that appear to be driving a tremendous amount of interest in Lucid Group and LCID stock today.

7 Safe Stocks that are Immune from China’s Market Volatility

Those worried about what's going on in China right now may want to consider these seven stocks we view as relatively safe from these woes.